论文部分内容阅读
目的:探讨进展性脑卒中的有效治疗方法。方法:66例进展性脑卒中病人随机分为2组,治疗组:东菱克栓酶联合低分子肝素及阿斯匹林;对照组:东菱克栓酶联合低分子肝素组。结果:在治疗组中,30天后的神经功能评分明显优于对照组。有2例出现颅内出血,无死亡病例。结论:东菱克栓酶联合低分子肝素及阿斯匹林可以进一步阻止某些难治性进展性脑卒中的病情加重,且具有安全性。
Objective: To explore the effective treatment of stroke. Methods: Sixty-six patients with progressive stroke were randomly divided into two groups. The treatment group was: tamoxifen combined with low molecular weight heparin and aspirin; the control group: tamoxifen combined with low molecular weight heparin. Results: In the treatment group, neurological scores after 30 days were significantly better than those of the control group. There are 2 cases of intracranial hemorrhage, no deaths. Conclusion: Batroxobin combined with low molecular weight heparin and aspirin can further prevent the progression of some refractory and progressive stroke, and it is safe.